Mycobacterium tuberculosis DNA Gyrase as a Target for Drug Discovery

E-ISSN： 2212-3989|7|2|159-168

ISSN： 1871-5265

Source： Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.7, Iss.2, 2007-01, pp. : 159-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Purine Metabolism in Mycobacterium tuberculosis as a Target for Drug Development

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

Navigating tuberculosis drug discovery with target-based screening

By Miller Christopher H O'Toole Ronan F

Expert Opinion on Drug Discovery, Vol. 6, Iss. 8, 2011-08 ,pp. : 839-854

Informa Healthcare

Access to resources Recommend Favorite

FtsZ: A Novel Target for Tuberculosis Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 527-543

Bentham Science Publishers

Access to resources Recommend Favorite

The Cell-Wall Core of Mycobacterium tuberculosis in the Context of Drug Discovery.

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-03 ,pp. : 475-488

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide deformylase – a promising therapeutic target for tuberculosis and antibacterial drug discovery

By Sharma Anshika Khuller Gopal K Sharma Sadhna

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 753-765

Informa Healthcare

Access to resources Recommend Favorite